- Role
- Country
- Date of registration
- Address
IL-MF-0000183683903172CE01MetaVision is an EU MDR-regulated medical device registered in EUDAMED. It is classified as Class IIb. Manufactured by iMDsoft Ltd. Placed on the EU market in Netherlands. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on May 11, 2026
729011689MetaVisionX6Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
(01)00007290116893
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Contains latex
A "contains latex" flag warns that a device contains natural rubber latex, which can trigger allergic reactions in sensitive patients.
CMR substance
A CMR flag warns that a device contains a substance that is carcinogenic, mutagenic or toxic to reproduction above a defined threshold.
Endocrine-disrupting substance
An endocrine-disruptor flag warns that a device contains a substance with endocrine-disrupting properties above a defined threshold.
Primary placement in Netherlands; available across 32 countries total.
| Country | On market since | Until |
|---|---|---|
| NetherlandsPrimary placement | Nov 30, 2023 | Nov 30, 2050 |
| Austria | Nov 30, 2023 | Nov 30, 2050 |
| Belgium | Nov 30, 2023 | Nov 30, 2050 |
| Bulgaria | Nov 30, 2023 | Nov 30, 2050 |
| Cyprus | Nov 30, 2023 | Nov 30, 2050 |
| Czechia | Nov 30, 2023 | Nov 30, 2050 |
| Germany | Nov 30, 2023 | Nov 30, 2050 |
| Denmark | Nov 30, 2023 | Nov 30, 2050 |
| Estonia | Nov 30, 2023 | Nov 30, 2050 |
| EL | Nov 30, 2023 | Nov 30, 2050 |
| Spain | Nov 30, 2023 | Nov 30, 2050 |
| Finland | Nov 30, 2023 | Nov 30, 2050 |
| France | Nov 30, 2023 | Nov 30, 2050 |
| Croatia | Nov 30, 2023 | Nov 30, 2050 |
| Hungary | Nov 30, 2023 | Nov 30, 2050 |
| Ireland | Nov 30, 2023 | Nov 30, 2050 |
| Iceland | Nov 30, 2023 | Nov 30, 2050 |
| Italy | Nov 30, 2023 | Nov 30, 2050 |
| Liechtenstein | Nov 30, 2023 | Nov 30, 2050 |
| Lithuania | Nov 30, 2023 | Nov 30, 2050 |
| Luxembourg | Nov 30, 2023 | Nov 30, 2050 |
| Latvia | Nov 30, 2023 | Nov 30, 2050 |
| Malta | Nov 30, 2023 | Nov 30, 2050 |
| Norway | Nov 30, 2023 | Nov 30, 2050 |
| Poland | Nov 30, 2023 | Nov 30, 2050 |
| Portugal | Nov 30, 2023 | Nov 30, 2050 |
| Romania | Nov 30, 2023 | Nov 30, 2050 |
| Sweden | Nov 30, 2023 | Nov 30, 2050 |
| Slovenia | Nov 30, 2023 | Nov 30, 2050 |
| Slovakia | Nov 30, 2023 | Nov 30, 2050 |
| Türkiye | Nov 30, 2023 | Nov 30, 2050 |
| XI | Nov 30, 2023 | Nov 30, 2050 |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
00007290116893Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
729011689MetaVisionX66.20 and upUDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
MDR risk classes
MDR risk classes rank medical devices from lowest risk (Class I) to highest (Class III), which determines how much regulatory scrutiny they face.
European Medical Device Nomenclature — the EU product classification assigned to this device.
V92MEDICAL DEVICE SOFTWARE - NOT INCLUDED IN OTHER CLASSESCertificate health across this manufacturer's portfolio.
3903172CE01IssuedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →